from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0242c/fabG4

LFCtreatmentdescriptionclass of inhibitor

-0.245

Amikacinug/mL Amikacintranslation

-0.936

Cap5-10ug/mL Capreomycintranslation

-2.030

Rox10-50 ug/mL Roxithromycintranslation

-0.639

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.127

Rif0.2-5ug/mL Rifampicintranscription

-0.221

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.344

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.446

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.013

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.041

Clofazimine10-13 ug/mL Clofaziminerespiration

0.125

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.907

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.019

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.057

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.067

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.173

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.530

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.060

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.978

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.664

KCN5-20 ug/mL Potassium cyaniderespiration

-0.336

NaN30.2-2 mM Sodium aziderespiration

-0.923

Nigericin50 uM Nigericinrespiration

-0.184

TRC10-150 ug/mL Triclosanrespiration

-0.147

TRZ10-25 ug/mL Thioridazinerespiration

-0.085

Valinomycin0.5-10 uM Valinomycinrespiration

-1.360

ZnSO42 mM ZnSO4respiration

-1.057

menadione6-10 ug/mL Menadionerespiration

-0.449

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.088

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.536

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.083

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.613

NRP_1Non-replicating persistence stage 1dosRassociated

0.411

Amp0.2mg/mL AmpicillincellWall

0.576

Cephalexin20-100 ug/mL CephalexincellWall

-1.605

Cerulenin0.32-5 ug/mL CerulenincellWall

0.264

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.802

EMB10-20 ug/mL EthambutolcellWall

2.227

Eta12-40 ug/mL EthionamidecellWall

2.603

INH0.2-0.4 ug/mL IsoniazidcellWall

2.154

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.716

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.029

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.173

BZA0.12 mg/mL BenzamidearomaticAmides

-0.047

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.481

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.074

H2O24 mM hydrogen peroxideDNAdamaging

-0.468

Levo10 ug/mL LevofloxacinDNAdamaging

-0.010

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.039

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.501

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.612

UVUV-irradiationDNAdamaging

-0.164

ARP41-4 ug/mL Antitubercular compound ARP4?

0.430

Antimycin12.5-50 ug/mL Antimycin A?

-0.048

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.039

PA_110-50 ug/mL Antitubercular compound PA-1?

0.116

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.494

PA8240.2-2 ug/mL PA-824?

0.560

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.951

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.383

Verapamil50 uM Verapamil?

0.287

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.182

methoxatin10-20 ug/mL Methoxatin?